{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:58:57Z","timestamp":1768895937291,"version":"3.49.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Dev Behav Pediatr"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Children with congenital heart disease (CHD) are at increased risk for attention-deficit\/hyperactivity disorder (ADHD). The aim of this study was to determine whether children with CHD and ADHD clinically treated with stimulant medication were at increased risk for changes in cardiovascular parameters or death compared with CHD-matched controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this retrospective cohort study, patients with CHD + ADHD treated with stimulant medication (exposed group [EG]) were matched by CHD diagnosis and visit age to patients not on stimulants (nonexposed group [NEG]). Cardiovascular parameters (heart rate [HR] and systolic and diastolic blood pressure [SBP and DBP]) and electrocardiograms (ECGs) from medical records over 12 months were compared using mixed effects models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Cardiovascular parameters for 151 children with CHD (mean age 8 \u00b1 4 years) were evaluated (N = 46 EG and N = 105 NEG). Stimulant medication use was not associated with sudden cardiac death. HR and SBP did not significantly change over time in the EG and remained similar between groups. EG children had higher DBP compared with NEG children over time (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001). Group \u00d7 time interactions for HR, SBP, and DBP were not different between the EG and NEG. QTc was not significantly different between the EG and NEG (447 ms vs 439 ms, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.23). EG children demonstrated improvement in ADHD symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Stimulant medication use in children with CHD was not associated with clinically significant changes in cardiovascular parameters compared with controls. Stimulants should be considered for ADHD treatment in children with CHD when prescribed with appropriate monitoring and coordination with the cardiologist.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dbp.0000000000001187","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:06:29Z","timestamp":1682035589000},"page":"e247-e254","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Stimulant Medication Treatment in Children with Congenital Heart Disease and Attention-Deficit\/Hyperactivity Disorder: Cardiovascular Outcomes"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6038-6740","authenticated-orcid":false,"given":"Pon","family":"Trairatvorakul","sequence":"first","affiliation":[{"name":"Division of Growth and Development, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand;"},{"name":"Center of Excellence for Maximizing Children's Developmental Potential, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jareen","family":"Meinzen-Derr","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh","family":"Heydarian","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"},{"name":"Division of Cardiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Mason","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"},{"name":"Division of Developmental and Behavioral Pediatrics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2854-446X","authenticated-orcid":false,"given":"Julia S.","family":"Anixt","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"},{"name":"Division of Developmental and Behavioral Pediatrics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"R1-20250716","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.CIR.89.2.923","article-title":"Cardiovascular health and disease in children: current status. A special writing group from the task force on children and youth, American Heart Association","volume":"89","author":"Moller","year":"1994","journal-title":"Circulation"},{"key":"R2-20250716","doi-asserted-by":"crossref","first-page":"e002846","DOI":"10.1161\/JAHA.115.002846","article-title":"Long-term survival of individuals born with congenital heart disease: a systematic review and meta-analysis","volume":"5","author":"Best","year":"2016","journal-title":"J Am Heart Assoc."},{"key":"R3-20250716","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIR.0b013e318265ee8a","article-title":"Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association","volume":"126","author":"Marino","year":"2012","journal-title":"Circulation"},{"key":"R4-20250716","doi-asserted-by":"crossref","first-page":"e20154675","DOI":"10.1542\/peds.2015-4675","article-title":"Neurocognitive development after pediatric heart surgery","volume":"137","author":"Sterken","year":"2016","journal-title":"Pediatrics"},{"key":"R5-20250716","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jtcvs.2010.07.069","article-title":"Is cardiac diagnosis a predictor of neurodevelopmental outcome after cardiac surgery in infancy?","volume":"140","author":"Gaynor","year":"2010","journal-title":"J Thorac Cardiovasc Surg."},{"key":"R6-20250716","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCULATIONAHA.111.026963","article-title":"Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: neuropsychological assessment and structural brain imaging","volume":"124","author":"Bellinger","year":"2011","journal-title":"Circulation"},{"key":"R7-20250716","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.athoracsur.2012.02.011","article-title":"Neurodevelopmental outcomes after open heart operations before 3 months of age","volume":"93","author":"Sananes","year":"2012","journal-title":"Ann Thorac Surg."},{"key":"R8-20250716","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/S1047951108003454","article-title":"Behaviour at eight years in children with surgically corrected transposition: the Boston Circulatory Arrest Trial","volume":"19","author":"Bellinger","year":"2009","journal-title":"Cardiol Young."},{"key":"R9-20250716","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S1047951114000547","article-title":"The prevalence of attention-deficit\/hyperactivity disorder following neonatal aortic arch repair","volume":"25","author":"Sistino","year":"2015","journal-title":"Cardiol Young."},{"key":"R10-20250716","doi-asserted-by":"crossref","first-page":"e20201693","DOI":"10.1542\/peds.2020-1693","article-title":"Mental health disorders in children with congenital heart disease","volume":"147","author":"Gonzalez","year":"2021","journal-title":"Pediatrics"},{"key":"R11-20250716","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PEC.0b013e31827b5663","article-title":"Acute myocardial infarction induced by concurrent use of Adderall and alcohol in an adolescent","volume":"29","author":"Sharma","year":"2013","journal-title":"Pediatr Emerg Care."},{"key":"R12-20250716","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.107.189473","article-title":"Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit\/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing","volume":"117","author":"Vetter","year":"2008","journal-title":"Circulation"},{"key":"R13-20250716","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/DBP.0b013e31318185dc14","article-title":"American Academy of Pediatrics\/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008","volume":"29","year":"2008","journal-title":"J Dev Behav Pediatr."},{"key":"R14-20250716","doi-asserted-by":"crossref","first-page":"e4627","DOI":"10.1136\/bmj.e4627","article-title":"Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study","volume":"345","author":"Winterstein","year":"2012","journal-title":"BMJ"},{"key":"R15-20250716","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","article-title":"ADHD drugs and serious cardiovascular events in children and young adults","volume":"365","author":"Cooper","year":"2011","journal-title":"N Engl J Med."},{"key":"R16-20250716","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1089\/cap.2014.0020","article-title":"Cardiovascular safety of stimulants in children with attention-deficit\/hyperactivity disorder: a nationwide prospective cohort study","volume":"24","author":"Dalsgaard","year":"2014","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"R17-20250716","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/11532570-000000000-00000","article-title":"Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children?","volume":"12","author":"Elia","year":"2010","journal-title":"Pediatr Drugs."},{"key":"R18-20250716","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4088\/JCP.v64n1004","article-title":"Methylphenidate treatment for attention-deficit\/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study","volume":"64","author":"Gothelf","year":"2003","journal-title":"J Clin Psychiatry."},{"key":"R19-20250716","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1017\/S1047951120004965","article-title":"Treatment of attention deficit\/hyperactivity disorder in children with CHD","volume":"31","author":"Pierick","year":"2021","journal-title":"Cardiol Young."},{"key":"R20-20250716","doi-asserted-by":"crossref","first-page":"1020961","DOI":"10.3389\/fnins.2022.1020961","article-title":"The use of attention-deficit hyperactivity disorder medications in cardiac disease","volume":"16","author":"Topriceanu","year":"2022","journal-title":"Front Neurosci."},{"key":"R21-20250716","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00787-012-0346-x","article-title":"How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis","volume":"22","author":"Prasad","year":"2013","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"R22-20250716","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/DBP.0b013e31827a3a22","article-title":"The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population","volume":"34","author":"Bard","year":"2013","journal-title":"J Dev Behav Pediatr."},{"key":"R23-20250716","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jpepsy\/jsg046","article-title":"Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population","volume":"28","author":"Wolraich","year":"2003","journal-title":"J Pediatr Psychol."},{"key":"R24-20250716","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S104795111600072X","article-title":"High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic","volume":"27","author":"Goldenberg","year":"2017","journal-title":"Cardiol Young."},{"key":"R27-20250716","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1017\/S1047951105002398","article-title":"Current insights regarding neurological and developmental abnormalities in children and young adults with complex congenital cardiac disease","volume":"16","author":"Wernovsky","year":"2006","journal-title":"Cardiol Young."},{"key":"R28-20250716","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(10)62226-X","article-title":"Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies","volume":"377","author":"Fleming","year":"2011","journal-title":"Lancet"},{"key":"R29-20250716","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00246-012-0162-6","article-title":"Attention-deficit\/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason","volume":"33","author":"Batra","year":"2012","journal-title":"Pediatr Cardiol."},{"key":"R30-20250716","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/MOP.0000000000000388","article-title":"Attention deficit hyperactivity disorder medications in children with heart disease","volume":"28","author":"Berger","year":"2016","journal-title":"Curr Opin Pediatr."},{"key":"R31-20250716","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJM199604183341607","article-title":"Sudden death from cardiac causes in children and young adults","volume":"334","author":"Liberthson","year":"1996","journal-title":"N Engl J Med."},{"key":"R32-20250716","doi-asserted-by":"crossref","first-page":"118B","DOI":"10.1016\/S0735-1097(85)80540-4","article-title":"Sudden unexpected death in children and adolescents","volume":"5","author":"Driscoll","year":"1985","journal-title":"J Am Coll Cardiol."},{"key":"R33-20250716","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3928\/0090-4481-19910701-09","article-title":"Sudden death due to cardiovascular disease during childhood","volume":"20","author":"Silka","year":"1991","journal-title":"Pediatr Ann."},{"key":"R34-20250716","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fped.2014.00100","article-title":"Blood pressure, heart rate, and CNS stimulant medication use in children with and without ADHD: analysis of NHANES data","volume":"2","author":"Hailpern","year":"2014","journal-title":"Front Pediatr."},{"key":"R35-20250716","doi-asserted-by":"crossref","first-page":"i2550","DOI":"10.1136\/bmj.i2550","article-title":"Cardiovascular safety of methylphenidate among children and young people with attention-deficit\/hyperactivity disorder (ADHD): nationwide self controlled case series study","volume":"353","author":"Shin","year":"2016","journal-title":"BMJ"},{"key":"R36-20250716","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2006.05.002","article-title":"Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit\/hyperactivity disorder","volume":"61","author":"Donner","year":"2007","journal-title":"Biol Psychiatry."},{"key":"R37-20250716","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jpeds.2009.02.008","article-title":"Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder","volume":"155","author":"Hammerness","year":"2009","journal-title":"J Pediatr."}],"container-title":["Journal of Developmental &amp; Behavioral Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DBP.0000000000001187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T16:00:18Z","timestamp":1752681618000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DBP.0000000000001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dbp.0000000000001187","relation":{},"ISSN":["0196-206X"],"issn-type":[{"value":"0196-206X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"2022-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}